Get started
Author

Bruno Kovic

Observed names: B Kovic, Kovic, Bruno
Institution: Roche (Canada)
OpenAlex ID: A5046530615
Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies
2016 · Feng Xie, Bruno Kovic, et al. · PharmacoEconomics · 202
Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology
2018 · Bruno Kovic, Xuejing Jin, et al. · JAMA Internal Medicine · 144
PDF
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
2021 · Nicholas Turner, Rebecca A. Dent, et al. · Breast Cancer Research and Treatment · 92
PDF
Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme
2015 · Bruno Kovic, Feng Xie · Journal of Clinical Oncology · 51
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study
2021 · John Mascarenhas, Francesco Passamonti, et al. · Blood Advances · 26
PDF
Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey
2017 · Bruno Kovic, Michael J. Zoratti, et al. · Journal of Clinical Epidemiology · 16
Efficacy, safety and patient reported outcomes (PROs) from the phase III IMbrave050 trial of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation.
2023 · Masatoshi Kudo, Minshan Chen, et al. · Journal of Clinical Oncology · 12
PDF
Association between progression-free survival and health-related quality of life in oncology: a systematic review protocol
2016 · Bruno Kovic, Gordon Guyatt, et al. · BMJ Open · 11
PDF
Safety and Efficacy of Idasanutlin in Patients (pts) with Hydroxyurea (HU)-Resistant/Intolerant Polycythemia Vera (PV): Results of an International Phase II Study
2020 · John Mascarenhas, Brian Higgins, et al. · Blood · 10
IMbrave050: Efficacy, safety and patient-reported outcomes (PROs) for adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in hepatocellular carcinoma (HCC) patients at high risk of disease recurrence after resection or ablation
2023 · Ahmed Kaseb, Minshan Chen, et al. · Journal of Hepatology · 2
Understanding breast cancer (BC) from the patient (pt) perspective: A qualitative study of symptoms, impacts and health-related quality of life (HRQoL) in hormone receptor-positive, HER2-negative (HR+, HER2–) BC.
2024 · Bruno Kovic, Anna Steenrod, et al. · Journal of Clinical Oncology
Resource use and cost associated with computerized decision support system and usual care in managing patients with atrial fibrillation: analysis of IMPACT-AF randomized trial data
2023 · Brittany Humphries, Jafna L Cox, et al. · BMC Medical Informatics and Decision Making
PDF
EE528 Resource Use and Costs Associated With Computerized Decision Support System for Managing Patients With Atrial Fibrillation
2022 · B Humphries, J Cox, et al. · Value in Health
PDF
Putting the Meaning Into Meaningful Change Research
2021 · Jessica Braid, Susanne Clinch, et al. · Research Square
PDF
Evaluating the Association Between Progression-free Survival and Health-related Quality of Life in Cancer.
2017 · Kovic, Bruno · MacSphere (McMaster University)
PDF
Association between progression-free survival and health-related quality of life in oncology: A systematic review and regression analysis.
2017 · Bruno Kovic, Xuejing Jin, et al. · Journal of Clinical Oncology
Works count: 18
Citation count: 566
H-index: 9
I10-index: 9
Year
Topic
Type